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DOI: 10.1016/j.ajpath.2011.07.007This Month in AJPAlternative Lengthening of Telomeres in
Human Cancer Subtypes
Aminority of human cancers (10% to 15%) lack demonstra-
ble telomerase activity, and of these, some maintain proper
telomere lengths through a telomerase-independent mech-
anism termed alternative lengthening of telomeres (ALT).
Heaphy et al (Am J Pathol 2011, 179:1608–1615) as-
sessed the prevalence of ALT by comprehensively sur-
veying the ALT phenotype in a broad range of human
cancers. In total, tumors from 94 different cancer sub-
types, 541 benign neoplasms, and 264 normal tissue
samples were assessed by combined telomere-specific
fluorescence in situ hybridization and immunofluores-
cence labeling for the transcription regulator promyelo-
cytic leukemia (PML) protein. ALT was observed in nearly
4% of all tumor specimens and was not observed in
benign neoplasms or normal tissues. This is the first de-
scription of ALT in multiple carcinomas and in multiple
brain tumor types. Therefore, further studies are war-
ranted to assess the potential prognostic significance
and unique biology of ALT-positive tumors.
Differential Expression of Oncogenic miRNAs
from the Same Gene Locus
The C13orf25 gene is amplified in some human cancers,
and six miRNAs, miR-17-92, are processed from the
gene transcript. Ji et al (Am J Pathol 2011, 179:1645–
1656) found that the amount of each miRNA varied rela-
tive to each other and to the primary transcript, with the
promoter being regulated by multiple transcription fac-
tors. Mutation of putative SP1-binding sites greatly re-
duced promoter activity. Mutation of a putative MYC-
binding site actually enhanced promoter activity, as the
inhibitory MYC family member MXI1 normally binds to this
region. Because these miRNAs are implicated in several
cancers and target genes that control cell proliferation
and survival, continued research is necessary to further
clarify the transcriptional control of the C13orf25 locus.
miRNAs Regulate Aquaporin-1 in Cirrhosis
and Hepatic Fibrogenesis
The water channel aquaporin-1 is overexpressed in cir-
rhosis, and changes in vasculature are observed in he-
patic fibrogenesis. Huebert et al (Am J Pathol 2011, 179:1851–1860) tested the role of the water channel in both
disease processes by generating aquaporin-1-knockout
mice. After bile duct ligation, wild-type mice overex-
pressed aquaporin-1 whereas aquaporin-1 knockout
mice demonstrated reduced angiogenesis, fibrosis, and
portal hypertension. Expression of aquaporin-1 protein,
but not mRNA, was increased by hyperosmolality in vitro,
suggesting posttranscriptional regulation. In fact, miR-
666 and miR-708 targeted aquaporin-1 mRNA and were
decreased in cirrhosis and in cells exposed to hyperos-
molality. Thus, these miRNAs mediate osmolar changes
via aquaporin-1 and may prove useful targets to amelio-
rate fibrosis and portal hypertension.
JNK Science in Rheumatoid Arthritis
The roles of the c-jun N-terminal kinases (JNK) JNK1 and
JNK2 in inflammatory arthritis have been previously in-
vestigated, but differences in models used and assays
used have made direct comparisons of their roles diffi-
cult. Using JNK1- or JNK2-deficient mice in two models
of arthritis, Denninger et al (Am J Pathol 2011, 179:1884–
1893) found JNK1 deficiency results in arthritis protec-
tion, whereas JNK2 deficiency aggravates disease. This
may be partly due to altered macrophage function affect-
ing T cell–mediated immunity. The results may explain
why modest beneficial effects are observed with broad-
spectrum JNK inhibitors and suggest that future thera-
pies should selectively target JNK1.
Sialylation Defects Characterize a Novel Form
of Thrombocytopenia
Thrombocytopenia, which frequently leads to spontane-
ous bleeding, can arise from several different causes.
Jones et al (Am J Pathol 2011, 179:1969–1977) observed
a new variant characterized by the appearance of giant
platelets and variable neutropenia. Platelets, neutrophils,
and monocytes exhibited deficient 2,3-sialylation, re-
sulting in greatly lessened sialyl–Lewis X but concomi-
tantly increased Lewis X surface expression. Platelets
from such patients bound to the asialoglycoprotein re-
ceptor (ASGP-R), a liver cell-surface protein essential for
removing desialylated thrombocytes from the circulation.
Thus, the lack of proper glycosylation effects cell re-
moval, leading to functional thrombocytopenia.
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